Observational basket trial to predict response to immune checkpoint inhibitors across solid tumors using a live tumor diagnostic platform (CYBRID-02)

Status: Open to Accrual

Learn more: 

• https://clinicaltrials.gov/study/NCT05520099

Study Contact: studies@hoosiercancer.org; (317) 921-2050.